Skip to main content

Military Health System

DHA leadership recognizes, advances 60th MDG mission

Image of Army Lt. Gen. Ronald Place visits Travis Air Force Base. Senior Airman Jessica McVean, 60th Inpatient Therapeutic Squadron technician, briefs Army Lt. Gen. Ronald Place, Defense Health Agency director, May 10, 2021, at Travis Air Force Base, California. Place and Command Sgt. Maj. Michael Gragg, DHA senior enlisted advisor. (U.S. Air Force photo by Senior Airman Jonathon Carnell)

Recommended Content:

Coronavirus & the MHS Response | Coronavirus and the COVID-19 Vaccine | MHS GENESIS: The Electronic Health Record

Army Lt. Gen. Ronald Place, Defense Health Agency director, and Command Sgt. Maj. Michael Gragg, DHA senior enlisted advisor, visited David Grant USAF Medical Center at Travis Air Force Base in California to recognize Airmen involved with COVID-19 relief and vaccine administration May 10, 2021, at Travis Air Force Base, California.

Place and Gragg traveled across multiple clinics in DGMC to have conversations with 60th Medical Group Airmen about their struggles and successes providing COVID-19 relief.

“This healthcare facility and installation responded very quickly to the pandemic,” Place said. “Getting feedback from the airmen who have and are responding to the pandemic is the best way forward to know what they need.”

Place said he maintains full confidence in the 60th MDG airmen to deliver on COVID-19 relief and vaccination efforts, but, across the Department of Defense, record management needs to be improved.

Senior Airman Jessica McVean briefs Army Lt. Gen. Ronald Place,
Senior Airman Jessica McVean, 60th Inpatient Therapeutic Squadron technician, briefs Army Lt. Gen. Ronald Place, Defense Health Agency director, May 10, 2021, at Travis Air Force Base, California. Place and Command Sgt. Maj. Michael Gragg, DHA senior enlisted advisor. (Photo by Air Force Senior Airman Jonathon Carnell.)

From the 60th MDG Intensive Care Unit to the COVID-19 vaccine team, Place stressed the importance of standardizing record keeping throughout the DOD.

“Through all the trials and tribulations that we’ve gone through as a military, it’s important that our medical providers are all trained on the same system,” Place said.

That system is MHS GENESIS, an electronic health record that went live at Travis AFB on Sept. 7, 2019.

The system is designed to allow TRICARE beneficiaries to exchange secure messages with their care team; schedule medical appointments and access notes, labs and medications; and request prescription renewals online.

“This file system is a great resource for us to keep track of Department of Defense personnel and beneficiaries who have received their vaccinations,” Place said. “The pilot phase of MHS GENESIS at Travis AFB showed a positive impact to patient care.”

On April 24, 2021, the MHS deployed the MHS GENESIS system to 25 military hospitals and clinics across 12 states, bringing the MHS GENESIS deployment to nearly 30% complete, according to the Health.mil website that holds a timeline of MHS GENESIS progression points.

Place and Gragg will continue touring military installations to support MHS leaders with the transition to MHS GENESIS.

You also may be interested in...

Consolidated Department of Defense Coronavirus Disease 2019 Force Health Protection Guidance

Policy

Consolidates and updates the Department’s guidance regarding vaccination verification, vaccination status, COVID-19 testing, surveillance and screening testing, personnel protection on-site mask requirements, (e.g., DHA military medical treatment facilities, meetings, travel), and the protection of personally identifiable information.

DHA-IPM 20-004: Department of Defense (DOD) Coronavirus Disease 2019 (COVID-19) Vaccination Program Implementation

Policy

Establishes the Defense Health Agency’s procedures to implement instructions, assign responsibilities, and prescribe procedures for the DHA’s implementation of the DOD’s COVID-19 Vaccination Program.

Coronavirus Disease 2019 Vaccination Attestation, Screening Testing, and Vaccination Verification

Policy

This memorandum provides guidance on the implementation of vaccination, attestation, and testing requirements in accordance with the References listed in Attachment 1 to reduce the transmission of the virus that causes COVID-19.

Medical Logistics Guidance for the DoD Coronavirus Disease 2019 (COVID-19) Vaccination Program

Policy

Establishes the DHA's procedures for ordering, receiving, and managing COVID-19 Vaccines inventory and ancillary kits for enduring COVID-19 support.

TAB A MEO COVID19 Medical Coding Policy

Policy

Memorandum for DHA Staff - Military Medical Treatment Facilities to Implement Updated DHA COVID-19 Medical Coding Policy

DHA COVID19 Medical Coding PolicyV5 1v

Policy

Establishes the DHA procedures to standardize the coding for Coronavirus 2019 (COVID-19) within military medical treatment facilities (MTFs). This memorandum replaces DHA-Policy Memorandum 20-003 of July 1, 2020. Attachment 1 was updated to include the 2021 procedure and diagnosis codes for COVID-19, including the new vaccination and treatment codes.

Supplemental Guidance for Providing DOD Coronavirus Disease 2019 Vaccines to DOD Contractor Employees and Select Foreign Nationals

Policy

This memorandum provides supplemental guidance on the provision of coronavirus disease 2019 (COVID-19) vaccines, in accordance with reference (a). The Defense Health Agency (DHA) is the lead coordinating DOD Component for executing this guidance, in coordination with the Military Departments and other DOD Components as appropriate.

HA Guidance for Coronavirus Disease 2019 (COVID-19) Laboratory Pre-Testing Questionnaire

Policy

This memorandum provides guidance for a COVID-19 laboratory pre-testing questionnaire that will be mandatory for all Active Duty Service members and encouraged for all other DOD beneficiaries treated at military medical treatment facilities.

Executive Order on Ensuring Access to United States Government COVID-19 Vaccines

Policy

This EO outlines who should receive priority access to COVID-19 vaccines developed in the United States or procured by the United States Government (“United States Government COVID-19 Vaccines”).

Coronavirus Disease 2019 Vaccine Guidance

Policy

This memorandum provides guidance on the provision of coronavirus disease 2019 (COVID-19) vaccines. The Defense Health Agency (DHA) is the lead coordinating DOD Component for executing this guidance, in coordination with the Military Departments and other DOD Components.

Return to the Workplace Staffing Plan in the Coronavirus Disease 2019 Environment

Policy

Establishes the DHA's plan to return to full operations and support the whole-of-government response, during the Coronavirus Disease 2019 (COVID-19) pandemic

Military Medical Treatment Facilities to Implement Updated DHA COVID-19 Medical Coding Policy

Policy

The Defense Health Agency (DHA) Memorandum, based on the authority of References (a) and (b), and in accordance with the guidance of References (c) and (d), establishes the DHA’s procedures to standardize the coding for Coronavirus 2019 (COVID-19) Military Medical Treatment Facilities (MTFs). This memorandum cancels and replaces DHA- Policy Memorandum 20-003 of (13 April 2020). A change was issued since the cancelled Memorandum 20-003 of (13 April 2020), the Attachment titles were updated to reflect that Attachments 1, 2, and 4 are considered Policies as opposed to Guidance.

Showing results 1 - 12 Page 1 of 1
Refine your search
Last Updated: May 14, 2021
Follow us on Instagram Follow us on LinkedIn Follow us on Facebook Follow us on Twitter Follow us on YouTube Sign up on GovDelivery